強力なCas9阻害効果を持つ人工アミノ酸導入型・抗CRISPRタンパク質の開発

• Project/Area Number: 24K21107
• Research Category: Grant-in-Aid for Early-Career Scientists
• Allocation Type: Multi-year Fund
• Review Section: Basic Section 90120:Biomaterials-related
• Research Institution: Osaka University
• Principal Investigator: 塚本 智仁 大阪大学, 大学院薬学研究科, 招へい教員 (20977342)
• Project Period (FY): 2024-04-01 – 2027-03-31
• Project Status: Declined (Fiscal Year 2024)
• Budget Amount: ¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000); Fiscal Year 2026: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000); Fiscal Year 2025: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000); Fiscal Year 2024: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)